Previous Close | $89.88 |
AI Value | $248.65 |
Upside potential | +177% |
Transcat, Inc. (TRNS) is a leading provider of calibration, inspection, and laboratory instrument services, serving highly regulated industries such as aerospace, pharmaceuticals, and energy. The company operates through two segments: Service and Distribution. The Service segment offers calibration, repair, and inspection services, while the Distribution segment sells and rents test and measurement instruments. Transcat has established a strong market position in North America, leveraging its accredited laboratories and technical expertise to ensure compliance with stringent industry standards. Its competitive advantages include a broad service network, deep regulatory knowledge, and a reputation for precision and reliability.
Investment in automation and digital tools to enhance calibration efficiency and accuracy. Holds ISO/IEC 17025 accreditations for its laboratories.
Transcat, Inc. presents a compelling investment opportunity due to its strong position in the niche calibration and instrumentation market, supported by recurring revenue streams and regulatory tailwinds. However, investors should be mindful of competitive pressures and operational risks tied to regulatory compliance. The company's focus on expanding its service network and leveraging technological advancements positions it well for long-term growth.
Transcat 10-K filings (CIK: 0000099302), investor presentations, and industry reports from Bloomberg.
Historical valuation data is not available at this time.